Journal article icon

Journal article

The human milk oligosaccharide 3'sialyllactose reduces low-grade inflammation and atherosclerosis development in mice

Abstract:

Macrophages contribute to the induction and resolution of inflammation and play a central role in chronic low-grade inflammation in cardiovascular diseases caused by atherosclerosis. Human milk oligosaccharides (HMOs) are complex unconjugated glycans unique to human milk that benefit infant health and act as innate immune modulators. Here, we identify the HMO 3′sialyllactose (3′SL) as a natural inhibitor of TLR4-induced low-grade inflammation in macrophages and endothelium. Transcriptome analysis in macrophages revealed that 3′SL attenuates mRNA levels of a selected set of inflammatory genes and promotes the activity of liver X receptor (LXR) and sterol regulatory element binding protein-1 (SREBP1). These acute antiinflammatory effects of 3′SL were associated with reduced histone H3K27 acetylation at a subset of LPS-inducible enhancers distinguished by preferential enrichment for CCCTC-binding factor (CTCF), IFN regulatory factor 2 (IRF2), B cell lymphoma 6 (BCL6), and other transcription factor recognition motifs. In a murine atherosclerosis model, both s.c. and oral administration of 3′SL significantly reduced atherosclerosis development and the associated inflammation. This study provides evidence that 3′SL attenuates inflammation by a transcriptional mechanism to reduce atherosclerosis development in the context of cardiovascular disease.

Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1172/jci.insight.181329

Authors



More from this funder
Funder identifier:
https://ror.org/03x94j517
Grant:
MR/V010182/1
More from this funder
Funder identifier:
https://ror.org/01cwqze88
Grant:
R35GM119850
DK09118330
DK113592
DK063491
HD089067
HL140898
HL088093


Publisher:
American Society for Clinical Investigation
Journal:
JCI Insight More from this journal
Volume:
9
Issue:
21
Article number:
e181329
Publication date:
2024-09-26
Acceptance date:
2024-09-24
DOI:
EISSN:
2379-3708
Pmid:
39325548


Language:
English
Keywords:
Pubs id:
2032636
Local pid:
pubs:2032636
Deposit date:
2024-12-20

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP